Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our aim is to give women more control about how IVF is performed. As an alternative to conventional IVF, we offer a more natural way of obtaining oocytes for IVF, without the burden and risks of systemic ovarian stimulation with gonadotropins. Our new disruptive technology — CAPA-IVF — requires only two days of hormone stimulation or none of all, thus avoiding risks and side reactions for the patients. CAPA-IFV can also...
Our aim is to give women more control about how IVF is performed. As an alternative to conventional IVF, we offer a more natural way of obtaining oocytes for IVF, without the burden and risks of systemic ovarian stimulation with gonadotropins. Our new disruptive technology — CAPA-IVF — requires only two days of hormone stimulation or none of all, thus avoiding risks and side reactions for the patients. CAPA-IFV can also be used to preserve fertility in women who have gynecological cancers and would like to preserve their fertility.

List your booth number for exhibitions, ask us